The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clearance (L/h)
Timeframe: Through study completion, an average of 30 days
Volume of Distribution (L)
Timeframe: Through study completion, an average of 30 days